The subfornical organ is a nucleus for gut-derived T cells that regulate behaviour
- PMID: 40437096
- DOI: 10.1038/s41586-025-09050-7
The subfornical organ is a nucleus for gut-derived T cells that regulate behaviour
Abstract
Specialized immune cells that reside in tissues orchestrate diverse biological functions by communicating with parenchymal cells1. The contribution of the innate immune compartment in the meninges and the central nervous system (CNS) is well-characterized; however, whether cells of the adaptive immune system reside in the brain and are involved in maintaining homeostasis is unclear2-4. Here we show that the subfornical organ (SFO) of the brain is a nucleus for parenchymal αβ T cells in the steady-state brain in both mice and humans. Using unbiased transcriptomics, we show that these extravascular T cells in the brain are distinct from meningeal T cells: they secrete IFNγ robustly and express tissue-residence proteins such as CXCR6, which are required for their retention in the brain and for normal adaptive behaviour. These T cells are primed in the periphery by the microbiome, and traffic from the white adipose and gastrointestinal tissues to the brain. Once established, their numbers can be modulated by alterations to either the gut microbiota or the composition of adipose tissue. In summary, we find that CD4 T cells reside in the brain at steady state and are anatomically concentrated in the SFO in mice and humans; that they are transcriptionally and functionally distinct from meningeal T cells; and that they secrete IFNγ to maintain CNS homeostasis through homeostatic fat-brain and gut-brain axes.
© 2025. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: D.A.H. has received research funding from Bristol Myers Squibb, Novartis, Sanofi and Genentech, and has been a consultant for Bayer Pharmaceuticals, Repertoire, Bristol Myers Squibb, Compass Therapeutics, EMD Serono, Genentech, Juno Therapeutics, Novartis, Proclara Biosciences, Sage Therapeutics and Sanofi Genzyme. A.W. has received research funding from NGM Biopharmaceuticals and AstraZeneca; has been a consultant for Seranova Bio, the Column Group and Soleil Labs; and is on the scientific advisory board for NGM Biopharmaceuticals.
References
-
- Jaschke, N. P. & Wang, A. Integrated control of leukocyte compartments as a feature of adaptive physiology. Immunity 58, 279–294 (2025). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials